BCR and neoplasm: However, if we combined the BCR and early treatment as criteria to evaluate impact of the zonal origin, TZ tumours had a significant lower incidence in BCR/early treatment compared to PZ/CZ tumours with GS = 4 + 3 (TZ 9.65% vs PZ/CZ 20.49%, p = 0.004).